Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Phibro Animal Health (PAHC) Cost of Revenue (2016 - 2026)

Phibro Animal Health has reported Cost of Revenue over the past 14 years, most recently at $241.3 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 16.33% year-over-year to $241.3 million; the TTM value through Dec 2025 reached $997.3 million, up 32.28%, while the annual FY2025 figure was $896.3 million, 27.21% up from the prior year.
  • Cost of Revenue for Q4 2025 was $241.3 million at Phibro Animal Health, down from $244.1 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $268.7 million in Q2 2025 and troughed at $142.6 million in Q1 2021.
  • A 5-year average of $185.8 million and a median of $174.1 million in 2022 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: fell 0.15% in 2023 and later skyrocketed 44.45% in 2025.
  • Year by year, Cost of Revenue stood at $162.0 million in 2021, then grew by 3.22% to $167.3 million in 2022, then increased by 2.43% to $171.3 million in 2023, then grew by 21.05% to $207.4 million in 2024, then increased by 16.33% to $241.3 million in 2025.
  • Business Quant data shows Cost of Revenue for PAHC at $241.3 million in Q4 2025, $244.1 million in Q3 2025, and $268.7 million in Q2 2025.